---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-013266"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T23:13:15.565011+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma hires Deloitte to find out-licensing partner for D-MNA (BCC)

## Summary
- Deloitte appointed exclusive lead financial adviser for out-licensing D-MNA for basal cell carcinoma.
- Company will pay Deloitte retainer plus contingent success fee if a transaction closes.
- Engagement letter signed July 29, 2025; no partner identified yet.

## SEC filing metadata
- accession: 0001062993-25-013266
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299325013266/0001062993-25-013266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299325013266/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-013266
- JSON: https://secwatch.observer/filing/0001062993-25-013266.json
- Plain text: https://secwatch.observer/filing/0001062993-25-013266.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.